Shufen Xu

机构：Second Affiliated Hospital of Nanjing Medical University

发表论文 28 篇 · 总被引 776 次 · h-index 14

代表论文

• AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery (2024 · Nature Communications · 被引 185)
• Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects (2023 · Proceedings of the National Academy of Sciences · 被引 148)
• Tumor‐Tailored Ionizable Lipid Nanoparticles Facilitate IL‐12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy (2024 · Advanced Materials · 被引 95)
• m6A Modification of Long Non-Coding RNA HNF1A-AS1 Facilitates Cell Cycle Progression in Colorectal Cancer via IGF2BP2-Mediated CCND1 mRNA Stabilization (2022 · Cells · 被引 49)
• m6A modification of lncRNA ABHD11-AS1 promotes colorectal cancer progression and inhibits ferroptosis through TRIM21/IGF2BP2/ FOXM1 positive feedback loop (2024 · Cancer Letters · 被引 45)
• <p>Overexpressed long noncoding RNA <em>TUG1 </em>affects the cell cycle, proliferation, and apoptosis of pancreatic cancer partly through suppressing RND3 and MT2A</p> (2019 · OncoTargets and Therapy · 被引 37)